Connect with us

News

Dubai-Based Startup Huspy Helps Emiratis Buy Homes Online

Instead of having to wait months to secure a home mortgage, Huspy lets users search over 500 home loan options in seconds.

Published

on

dubai-based startup huspy helps emiratis buy homes online
Huspy

Buying a home is a stressful process. Not only is it becoming increasingly difficult to find reasonably priced properties that are also attractive to live in, but the mortgage process, which most buyers have to go through, is time-consuming and full of potential traps. While the first problem won’t most likely be solved any time soon, there’s one Dubai-based startup that’s actively trying to address the second issue, and its name is Huspy.

Essentially, Huspy is an online mortgage platform that facilitates hassle-free financing for people who would like to live in Dubai. It was founded in August 2020 by chief executive officer Jad Antoun and chief technology officer Khalid Al Ashmawy, who understand the local market through first-hand experience.

huspy application process

Huspy Application Process

“We started Huspy with the aim to disrupt one of the largest industries and bring the entire home loan process online. Customers are massively underserved where lack of visibility, poor customer experience, and overpayment are common problems. We want to solve for that,” said Antoun. “The team has built tools and systems to leverage technology in a highly operational business to give us the ability to provide customers with the best rates, faster mortgage close times and a great digital experience,” added Ashmawy.

Also Read: Sarwa Helps UAE Residents Easily Invest In Global Stocks

Instead of having to wait up to 10 weeks to secure a mortgage, Huspy lets its users search over 500 home loan options in seconds to find the one that fits them the best. That way, it’s possible to get a personalized home loan three times faster and secure the best price possible. Best of all, Huspy doesn’t charge its users broker fees at all. Instead, it makes money by charging the banks a commission for every loan.

Huspy is available on iOS as well as Android, and you can download it yourself right now to see what it has to offer. The startup is backed by leading tech investors, including VentureFriends, B&Y Ventures, and Plug and Play, so you know your mortgage will be in good hands.

Advertisement

📢 Get Exclusive Monthly Articles, Updates & Tech Tips Right In Your Inbox!

JOIN 17K+ SUBSCRIBERS

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

News

Orchid Plans To Find Out What’s Wrong With You Before You’re Born

According to CEO Noor Siddiqui, the company isn’t on a mission to make designer babies, but aims to beat genetic odds and relieve suffering.

Published

on

startup orchid plans to find out what's wrong with you before you're born
Orchid

Each day, around 400,000 babies are welcomed into the world. However, among those, a growing number will experience some kind of birth defect or inherited disease.

Noor Siddiqui, CEO of Orchid, hopes to “mitigate” unpleasant genetic surprises using genome sequencing technology to reveal a wealth of genetic information on which newborns will grow into healthy adults.

Until 2019, IVF specialists had access to under 1% of the human genome. The tests, called PGT-A and PGT-M, scanned a mere 1,000 data points in a genome comprising around 3 billion bases, offering a very limited dataset compared to the technology used by Orchid.

“Our chromosomes are like chapters in a book that make up the table of contents.” Explained Siddiqui. “[PGT-A and PGT-M tests] only examine the table of contents, whereas what Orchid is doing is like a spellcheck on the entire book.” Orchid’s genome sampling technology assesses “100 times the data, covering many more conditions.” In essence, an Orchid report covers three categories of common genetic issues: monogenic disorders, polygenic conditions, and de-novo mutations.

Also Read: Advancing MENA Health Through AI Vascular Age Analysis

Orchid’s technology raises many questions. Aside from the obvious ethical concerns, data privacy is the most obvious potential issue with the tests. Noor Siddiqui is keen to alleviate any concerns: “No data at Orchid is ever sold to any third parties. Parents are in complete control of their data. If they want to delete the data, we’re happy to delete it off of our servers. If they want to export the data, they can export the data. And if they want us to re-analyze the data, we can re-analyze the data”.

Compared to a lifetime of medical bills, gene therapy, and suffering, Orchid’s genome screening report has the potential to change the future lives of thousands of newborns worldwide.

Continue Reading

#Trending